Mentor buys female incontinence products:
This article was originally published in Clinica
Mentor has bought assets relating to soft silicone intra-vaginal devices for the non-surgical treatment of incontinence from DesChutes Medical Products for an undisclosed amount. Santa Barbara, California-based Mentor already offers surgical treatments for urinary incontinence. Last month, Mentor completed the acquisition of Sanofi-Synthelabo subsidiary Porges, which makes urological products, for $32 million.
You may also be interested in...
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.